Antibiotics and Corticosteroids Market Size, Share 2019; Global Industry Analysis By Top Key Vendors, Growth, Business opportunities, By Drug Type, Diagnosis and End Users

Antibiotics or also called antibacterial are used to destroy or slow down growth of bacteria in the body. On the contrary, corticosteroids are used to treat the allergy and inflammatory condition. There are certain functions, which corticosteroids can perform while antibiotics cannot perform and vice-versa. In some cases, the physician prescribes the dose of antibiotics along with corticosteroids so that antibiotic will help attack the microorganism cell wall, while corticosteroids tackle inflammatory process. Corticosteroids also used to decrease the pain associated with inflammation by inhibiting chemical mediators. Over dosage or misuse of both compounds might lead to adverse effects such as failure of immune system.

Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-sample/781

Global Antibiotics and Corticosteroids Market- Drivers

Efficiency of combine treatment of antibiotics and corticosteroids on several chronic diseases to drive global antibiotics and corticosteroids market growth

The combine use of antibiotics and corticosteroids has proven to be highly efficient in the treatment of human respiratory syncytial virus infection (hRSV), Zika Virus, Ebola, Cepacia syndrome, S. Aureus arthritis, and pneumonia. According to the data published in Journal of Tropical Diseases and Public Health, in 2016, around 6.3 million children died in 2013, wherein 51.8% died due to infectious diseases and largest was accounted due to pneumonia for around 935,000 deaths. According to the same source, around 3.4 million children are infected with the human Respiratory syncytial virus (RSV), which is associated to acute lower respiratory infections (ALRI). Increasing initiatives by governmental authorities to support antibiotics and corticosteroids production is growth of the global antibiotic and corticosteroids market. For instance, introduction of Antibiotics Incentives Now (GAIN) act, which has the provisions to facilitate the development of therapy against antigen resistant pathogens is expected to propel the approval for antibiotics.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/781

Global Antibiotics and Corticosteroids Market- Restraints

However, adverse effect caused due to high intake or misuse of both antibiotics and corticosteroids, use in animals which are later consumed by humans, and regulations and policies on use of antibiotics and corticosteroids are expected to restrain growth of the global antibiotics corticosteroids market growth.

Rise in population with pneumonia is contributing to the growth of this disease segment in global antibiotics and corticosteroids market

The global antibiotics and corticosteroids market is segmented by application, by antibiotics type, by end user, by disease type, and by region

On the basis of application, the global antibiotics and corticosteroids market is segmented into

• Humans
• Veterinary

On the basis of antibiotic type, the global antibiotics and corticosteroids market is segmented into

• Macrolides
• Tetracycline
• Beta-lactams
• Lincosamides
• Glycopeptides
• Aminoglycosides
• Sulfonamides
• Others

On the basis of end user, global the antibiotics and corticosteroids market is segmented into

• Hospitals
• Medical clinics

On the basis of disease type, the global antibiotics and corticosteroids market is segmented into

• Pneumonia
• Cepasia Syndrome
• Human Respiratory syncytial virus (RSV) infection
• Aureus Arthritis
• Sinus Infection
• Others

To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/antibiotics-and-corticosteroids-market-781

Regional Analysis

Increasing prevalence of infectious diseases and established healthcare sector is fueling growth of the antibiotics and corticosteroids market in North America

Regional segmentation of antibiotics and corticosteroids market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, the Middle East and Africa. Among regions, North America accounts for the largest share in the global antibiotics and corticosteroids market. This is owing to high prevalence rate of respiratory syncytial virus (RSV) infection and the need for antibiotic and corticosteroids treatment of such diseases in the region. For instance, the Centers for Disease Control and Prevention (CDC), around 2.1 million children are diagnosed with RSV and 14, 000 adult population die due to this disease annually. Moreover, Latin America accounts for the major share in the global antibiotics and corticosteroids market followed by Asia Pacific, owing to the progress in pharmaceutical industry.

Competitive Landscape

The generic drug manufacturers account for the largest share in the global antibiotics and corticosteroid market, owing to presence of key drugs that are helping to generate the revenue with availability of few patent products. Key players in the market are focused on various growth strategies such as collaboration and agreement, in order to gain competitive edge in the market. For instance, in 2016, Pfizer entered into an agreement with AstraZeneca to acquire the commercialization and development right Pfizer’s business mostly outside the U.S.

Key players operating the global antibiotics and corticosteroids market include Novartis, Pfizer, GlaxoSmithKline (GSK), Abbott Laboratories, Sanofi, Johnson & Johnson, Merck, Sumitomo, AstraZeneca, Cipla, and Astellas Pharma.

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837